Tg Therapeutics TGTX
NASDAQ TGTX
$55.99 -0.72 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tg Therapeutics (TGTX) Change in Taxes (2025 - 2026)

Tg Therapeutics (TGTX) posted quarterly Change in Taxes of -$6.7 million for Q1 2026, down 1746.57% year-over-year from $408000.0 in Q1 2025, and down 1746.57% quarter-over-quarter from $408000.0 in Q1 2025.

Analysis

Tg Therapeutics (TGTX) Change in Taxes (2025 - 2026) Analysis & Trends

Tg Therapeutics' Change in Taxes history runs 2 years deep, the most recent figure standing at -$6.7 million for Q1 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Tg Therapeutics 7.97 Bn 7.29 Bn 199.14 Mn -6.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.13 Mn
Mar 31, 2026 -6.72 Mn
Jun 30, 2025 -2.68 Mn
Mar 31, 2025 408,000.00